Literature DB >> 11086048

Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity.

F J Quintana1, A Rotem, P Carmi, I R Cohen.   

Abstract

Nonobese diabetic (NOD) mice develop insulitis and diabetes through a process involving autoimmunity to the 60-kDa heat shock protein (HSP60). Treatment of NOD mice with HSP60 or with peptides derived from HSP60 inhibits this diabetogenic process. We now report that NOD diabetes can be inhibited by vaccination with a DNA construct encoding human HSP60, with the pcDNA3 empty vector, or with an oligonucleotide containing the CpG motif. Prevention of diabetes was associated with a decrease in the degree of insulitis and with down-regulation of spontaneous proliferative T cell responses to HSP60 and its peptide p277. Moreover, both the pcDNA3 vector and the CpG oligonucleotide induced specific Abs, primarily of the IgG2b isotype, to HSP60 and p277, and not to other islet Ags (glutamic acid decarboxylase or insulin) or to an unrelated recombinant Ag expressed in bacteria (GST). The IgG2b isotype of the specific Abs together with the decrease in T cell proliferative responses indicate a shift of the autoimmune process to a Th2 type in treated mice. These results suggest that immunostimulation by bacterial DNA motifs can modulate spontaneous HSP60 autoimmunity and inhibit NOD diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086048     DOI: 10.4049/jimmunol.165.11.6148

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Coordination between TLR9 signaling in macrophages and CD3 signaling in T cells induces robust expression of IL-30.

Authors:  Denada Dibra; Jeffry J Cutrera; Shulin Li
Journal:  J Immunol       Date:  2012-03-09       Impact factor: 5.422

2.  Ian4 is required for mitochondrial integrity and T cell survival.

Authors:  Malini Pandarpurkar; Leanne Wilson-Fritch; Silvia Corvera; Helle Markholst; Lars Hornum; Dale L Greiner; John P Mordes; Aldo A Rossini; Rita Bortell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

3.  DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice.

Authors:  A Gauvrit; M Debailleul; A-T Vu; P Sai; J-M Bach
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 4.  The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetes.

Authors:  Jean-François Bach; Lucienne Chatenoud
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

5.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: viruses, autoimmunity and immunoregulation.

Authors:  C M Filippi; M G von Herrath
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

Review 6.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

Review 7.  Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.

Authors:  Mark C Johnson; Bo Wang; Roland Tisch
Journal:  Hum Vaccin       Date:  2011-01-01

Review 8.  Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

Review 9.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

Review 10.  Targeting Innate Immunity for Type 1 Diabetes Prevention.

Authors:  James C Needell; Danny Zipris
Journal:  Curr Diab Rep       Date:  2017-09-27       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.